Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases.
about
Recent progress in West Nile virus diagnosis and vaccinationLimited Effects of Type I Interferons on Kyasanur Forest Disease Virus in Cell CultureNovel approaches and challenges to treatment of central nervous system viral infectionsWest Nile Virus: biology, transmission, and human infectionAlpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survivalProtective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virusIdentification of Novel Small-Molecule Inhibitors of West Nile Virus InfectionDifferential Effects of Mutations in NS4B on West Nile Virus Replication and Inhibition of Interferon SignalingWhy the West in West Nile virus infections?Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in ManInnate immune evasion by hepatitis C virus and West Nile virusProgress on the development of therapeutics against West Nile virusEpidemiological and clinical aspects on West Nile virus, a globally emerging pathogen.Transgenic models for cytokine-induced neurological disease.Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals.Protection against West Nile virus infection in mice after inoculation with type I interferon-inducing RNA transcripts.Cerebrospinal fluid biomarker candidates associated with human WNV neuroinvasive disease.Development of effective therapies against West Nile virus infection.Failure of interferon alpha-2b in a patient with West Nile virus meningoencephalitis and acute flaccid paralysis.Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis.Targeting host factors to treat West Nile and dengue viral infections.A review of the epidemiological and clinical aspects of West Nile virus.Acute flaccid paralysis due to West nile virus infection in adults: A paradigm shift entity.Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virusWest Nile virus infection and immunity.Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features.Neuroinvasive St. Louis Encephalitis Virus Infection in Solid Organ Transplant Recipients.The first reported case of West Nile encephalitis in Korea.West Nile Virus Infection in the Immunocompromised Patient.Arenavirus and West Nile virus in solid organ transplantation.Neglected infections of poverty in Texas and the rest of the United States: management and treatment options.Successful treatment of West Nile virus infection after approximately 3 weeks into the disease course.Exogenous interferon prolongs survival of rabies infected mice.Cytomegalovirus induces interferon-stimulated gene expression and is attenuated by interferon in the developing brain.West Nile virus
P2860
Q21284433-0E6D1C19-13A2-4777-97B3-539C8315B80AQ26699999-14B896A6-A6D0-44CF-BEC1-FCAA54478284Q26862449-D84DF4C4-AFBA-40C3-9596-E1DB4C3F4BAAQ26865618-A4FEDEFF-DCF9-4C4E-92F2-670398EB7293Q27472671-ECCB1DF9-A03A-4D51-8500-3E9BEC1677F8Q27472711-5EA80D6F-08F5-475B-84D8-4F187A792504Q27484983-5394B5C7-E268-4939-A345-7B7B2C468630Q27484997-43A56857-E3D6-4517-8898-3A281F0BB89DQ27486823-78804EE4-C81C-4962-9C1E-ABD8CE7DED6DQ27487937-2801C896-9D79-4734-8779-5D9010DFA130Q27489865-D080EA3F-B8F4-4DFD-A985-49297EF167A9Q27489893-54A0D3FA-2555-482A-9AAE-A700A607C0A2Q30250251-707C26CB-82DD-407D-8D82-6CC1BB3ABA37Q33926168-83D8811D-7F4A-44A8-870B-A2B42AC117BBQ34237824-216E3FC5-3950-4CFE-99E2-8CEDA63AEA5FQ34482403-99252F32-815D-4CB2-AE0E-A6DB37A3ACA2Q35138507-B9FBBA8D-E238-426E-A7C7-F780A66AB005Q36322125-91053C09-98C8-4ACC-A7FE-3BBD82C29554Q36322559-DB3B22A6-1985-4D35-AD8C-86925E278670Q37136479-3C1820DA-CC66-49C3-BCF3-B4B567AA9441Q37611829-443DAE58-AF62-4D8E-B3D6-69D80687719EQ37708659-16F8D3A3-D868-4719-AAA2-74FC05173C92Q37712155-7A7795B9-591B-4A6C-89BB-2AC1E97209CBQ37726746-0F0CF96A-6011-4975-AE28-5B3482DBAD1EQ38074266-E5FCCB24-AC0F-477A-AF85-9177BF4BAB3EQ38211715-FD0D66D2-4462-4D87-9663-1253717D53B9Q40059267-EBDF1D71-22C7-418E-8886-838F4F9B4A48Q40167373-786EF4C9-911C-41ED-8B58-64A00E59C5B6Q40228190-C90DAB78-FE5F-4B98-8BB3-5BCEDA5A1A53Q40255394-7C81789F-B187-4A38-BD3C-AFD230FE2FF0Q40281592-04DA8590-F6FB-4054-B167-85BD37063BA0Q40457234-AFB0CDD0-A887-4E16-B3AF-1594F9281937Q40986580-F08D54AC-1096-411C-9243-BBA3AD915373Q42957459-E6B0CB9A-D7BA-440F-A42E-46C54CD9679DQ56932479-CCA50179-EF02-4416-85AB-5087B982E6A6
P2860
Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases.
@en
type
label
Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases.
@en
prefLabel
Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases.
@en
P2093
P2860
P356
P1476
Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases.
@en
P2093
Alison G Freifeld
Andre C Kalil
Brandi Lesiak
David P Poage
Kim Bargenquast
Marcel P Devetten
Pierre Fayad
Sanjay Singh
P2860
P304
P356
10.1086/427945
P407
P577
2005-02-07T00:00:00Z